Rationale and Experience of Vitamin B12 Usage in Complex Therapy of COVID-19 and Post-COVID Syndrome

management of COVID-19.

Key points. The COVID-19 poses the greatest risk to older people and patients with diabetes mellitus type 2. These categories of patients often require long-term hospitalization and intensive care, and the prognosis of the disease and the risk of life-threatening complications are much higher than the average in the population. Determining the risk factors for a severe course of COVID-19 and the mechanisms of their occurrence helps to choose the optimal treatment tactics and significantly improve the prognosis of recovery, reduce the negative consequences of the disease, the so-called post-COVID syndrome, and shorten the rehabilitation period for patients after COVID-19. One of the hypotheses explaining the increased risk of severe COVID-19 in these groups of patients is vitamin B12 deficiency. Perhaps this factor is unifying for the elderly and patients with type 2 diabetes mellitus. Thus, the question arises whether the elimination of B12 deficiency will affect mortality from COVID-19 or recovery rates. In this review, we will analize the latest evidence that shows B12 is involved in many immunological, microbiological and hematological processes that are the target of coronavirus infection.

Conclusion. Our review data confirms the hypothesis that B12 deficiency is a potential risk factor for severe COVID-19, and replacement of this deficiency by prescribing vitamin B12 therapy can be considered as adjuvant therapy and prevention of complications for these categories of patients.

1. Li X., Xu S., Yu M., Wang K. et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J. Allergy Clin. Immunol. 2020;146(1):110–18. DOI: 10.1016/j.jaci.2020.04.006

2. Bliek-Bueno K., Mucherino S., Poblador-Plou B., González-Rubio F. et al. Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy. Int. J. Environ. Res. Public Health. 2021;18(22):11786. DOI: 10.3390/ijerph182211786

3. Angelidi A.M., Belanger M.J., Mantzoros C.S. Commentary: COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next. Metabolism. 2020;107:154245. DOI: 10.1016/j.metabol.2020.154245

4. Clemente-Suárez V.J., Ramos-Campo D.J., Mielgo-Ayuso J., Dalamitros A.A. et al. Nutrition in the actual COVID-19 pandemic. A narrative review. Nutrients. 2021;13(6):1924. DOI: 10.3390/nu13061924

5. Tamara A., Tahapary D.L. Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab. Syndr. 2020;14(4):655–9. DOI: 10.1016/j.dsx.2020.05.020

6. Gupta R., Hussain A., Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur. J. Clin. Nutr. 2020;74(6):864–70. DOI: 10.1038/s41430-020-0652-1

7. Cariou B., Hadjadj S., Wargny M., Pichelin M. et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500– 15. DOI: 10.1007/s00125-020-05180-x. Erratum in: Diabetologia. 2020 Jul 2.

8. Huang C., Wang Y., Li X., Ren L. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5

9. Muniyappa R., Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 2020;318(5):E736–41. DOI: 10.1152/ajpendo.00124.2020

10. Kumar A., Arora A., Sharma P., Anikhindi S.A. et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab. Syndr. 2020;14(4):535–45. DOI: 10.1016/j.dsx.2020.04.044

11. Zhang C., Wu Z., Li J.W., Zhao H. et al. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents. 2020;55(5):105954. DOI: 10.1016/j.ijantimicag.2020.105954

12. Nimer R.M., Khabour O.F., Swedan S.F., Kofahi H.M. The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization. Bosn. J. Basic Med. Sci. 2022;22(5):826–32. DOI: 10.17305/bjbms.2021.7009

13. Beigmohammadi M.T., Bitarafan S., Abdollahi A., Amoozadeh L. et al. The association between serum levels of micronutrients and the severity of disease in patients with COVID-19. Nutrition. 2021;91–92:111400. DOI: 10.1016/j.nut.2021.111400

14. Asad D., Shuja S.H. Role of folate, cobalamin, and probiotics in COVID-19 disease management [letter]. Drug Des. Devel. Ther. 2021;15:3709–10. DOI: 10.2147/DDDT.S333295

15. Shakeri H., Azimian A., Ghasemzadeh-Moghaddam H., Safdari M. et al. Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19. J. Med. Virol. 2022;94(1):141–6. DOI: 10.1002/jmv.27277

16. Akbari A., Koolivand Z., Mohamadi M.B., Zahedi A. et al. Determination of B vitamins by double-vortex-ultrasonic assisted dispersive liquidliquid microextraction and evaluation of their possible roles in susceptibility to COVID-19 infection: hybrid box-behnken design and genetic algorithm. J. Chromatogr. Sci. 2022;60(9):897–906. DOI: 10.1093/chromsci/bmab124

17. Speakman L.L., Michienzi S.M., Badowski M.E. Vitamins, supplements and COVID-19: a review of currently available evidence. Drugs Context. 2021;10:2021-6-2. DOI: 10.7573/dic.2021-6-2

18. Zhang L., Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J. Med. Virol. 2020;92(5):479–90. DOI: 10.1002/jmv.25707.

19. Baranovsky A.Yu., ed. Dietology. SPb.: Piter; 2017. 1104 p. (in Russian)

20. Batista K.S., Cintra V.M., Lucena P.A.F., Manhães-de-Castro R. et al. The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the muscle-gut-brain axis and implications for SARS-CoV-2 infection. Nutr. Rev. 2022;80(3):561–78. DOI: 10.1093/nutrit/nuab092

21. Sabry W., Elemary M., Burnouf T., Seghatchian J. et al. Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA). Transfus. Apher. Sci. 2020;59(1):102717. DOI: 10.1016/j.transci.2019.102717

22. Galmés S., Serra F., Palou A. Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients. 2020;12(9):2738. DOI: 10.3390/nu12092738

23. Wee A.K.H. COVID-19's toll on the elderly and those with diabetes mellitus — is vitamin B12 deficiency an accomplice? Med. Hypotheses. 2021;146:110374. DOI: 10.1016/j.mehy.2020.110374

24. Muhktar M., Sherry D., Keaver L., McHugh C.M. Metformin-induced B12 deficiency: still relevant today. Ir. J. Med. Sci. 2020;189(1): 409–10. DOI: 10.1007/s11845-019-02070-z

25. Luo P., Qiu L., Liu Y., Liu X.L. et al. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am. J. Trop. Med. Hyg. 2020;103(1):69–72. DOI: 10.4269/ajtmh.20-0375

26. Sharma S., Ray A., Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res. Clin. Pract. 2020;164:108183. DOI: 10.1016/j.diabres.2020.108183

27. Dedov I.I., Shestakova M.V., Mayorov A.Yu., eds. Standards of specialized diabetes care. 10th edition. Diabetes Mellitus. 2021;24(1S):1–148. (in Russian). DOI: 10.14341/DM12802

28. Gombart A.F., Pierre A., Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. DOI: 10.3390/nu12010236

29. Tamura J., Kubota K., Murakami H., Sawamura M. et al. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin. DOI: 10.1046/j.1365-2249.1999.00870.x

30. Dhar D., Mohanty A. Gut microbiota and COVID-19 — possible link and implications. Virus Res. 2020;285:198018. DOI: 10.1016/j.virusres.2020.198018

31. Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944–55.e8. DOI: 10.1053/j.gastro.2020.05.048

32. Eden T., McAuliffe S., Crocombe D., Neville J. et al. Nutritional parameters and outcomes in patients admitted to intensive care with COVID-19: a retrospective single-centre service evaluation. BMJ Nutr. Prev. Health. 2021;4(2):416–24. DOI: 10.1136/bmjnph-2021-000270

33. Koklesova L., Mazurakova A., Samec M., Biringer K. et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J. 2021;12(4):477–505. DOI: 10.1007/s13167-021-00263-0

34. Takhar A. Pernicious anaemia: switch to oral B12 supplementation to reduce risk of COVID-19 transmission. BMJ. 2020;369:m2383. DOI: 10.1136/bmj.m2383

35. Mehta P., McAuley D.F., Brown M., Sanchez E. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. DOI: 10.1016/S0140-6736(20)30628-0

36. Tan C.W., Ho L.P., Kalimuddin S., Cherng B.P.Z. et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020;79–80:111017. DOI: 10.1016/j.nut.2020.111017

37. Narayanan N., Nair D.T. Vitamin B12 may inhibit RNA-dependentRNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life. 2020;72(10):2112–20. DOI: 10.1002/iub.2359

38. Kandeel M., Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci. 2020;251:117627. DOI: 10.1016/j.lfs.2020.117627

39. Rocco A., Compare D., Coccoli P., Esposito C. et al. Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus. Gut. 2013;62(5):766–73. DOI: 10.1136/gutjnl-2012-302344

40. Jimenez-Guardeño J.M., Ortega-Prieto A.M., Moreno B.M., Maguire T.J.A. et al. Drug repurposing based on a quantum-inspired method versus classical fingerprintin uncovers potential antivirals against SARS-CoV-2. PLoS Comput. Biol. 2022;18(7):e1010330. DOI: 10.1371/journal.pcbi.1010330